menu
    • menu

    Company profile for OnKure Therapeutics

    NEW Drugs in Dev: 4
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer. As a team of veterans with a track record of successful drug discovery and development, we are leveraging our proven structure-based drug design approach to create a robust pipeline of drug candidates that are designed to achieve optimal tolerability and efficacy. OnKure is currently d...
    OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer. As a team of veterans with a track record of successful drug discovery and development, we are leveraging our proven structure-based drug design approach to create a robust pipeline of drug candidates that are designed to achieve optimal tolerability and efficacy. OnKure is currently developing its lead clinical candidate.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OnKure TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6707 Winchester Circle Suite 400 Boulder, Colorado 80301
    Telephone
    Telephone
    (720) 307-2892
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://onkuretherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/onkure-tx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OnKureTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onkure Therapeutics Reports Q3 2025 Financials & Business
    Onkure Therapeutics Reports Q3 2025 Financials & Business

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183068/0/en/OnKure-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Onkure Therapeutics Joins Investor Conferences
    Onkure Therapeutics Joins Investor Conferences

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180849/0/en/OnKure-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    OnKure Therapeutics Q2 2025 Financial Results and Business Update
    OnKure Therapeutics Q2 2025 Financial Results and Business Update

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3132114/0/en/OnKure-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share
    OnKure Therapeutics Q1 2025 Financial Results & Highlights
    OnKure Therapeutics Q1 2025 Financial Results & Highlights

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3074919/0/en/OnKure-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Business-Highlights.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    OnKure Therapeutics Reports Q4 and Full Year 2024 Results
    OnKure Therapeutics Reports Q4 and Full Year 2024 Results

    10 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/10/3040142/0/en/OnKure-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    10 Mar 2025
    Share Share
    OnKure To Present At Leerink, Stifel Investor Conferences
    OnKure To Present At Leerink, Stifel Investor Conferences

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036466/0/en/OnKure-Therapeutics-to-Present-at-Upcoming-Leerink-and-Stifel-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search